Diclofenac Sodium/misoprostol Tablet
NDC Package 42571-133-29
Package Information
Diclofenac Sodium/misoprostol tablets is diclofenac is used to reduce pain, swelling, and joint stiffness from arthritis. This formulation utilizes a tablet delivery system. Marketed by Micro Labs Limited, this product is identified by NDC 42571-133 and is authorized under FDA application ANDA204355.
Identification & Billing
- RxCUI: 1359105 - diclofenac sodium 75 MG / miSOPROStol 0.2 MG Delayed Release Oral Tablet
- RxCUI: 1359105 - diclofenac sodium 75 MG / misoprostol 0.2 MG Delayed Release Oral Tablet
- RxCUI: 1359105 - diclofenac sodium (enteric coated core) 75 MG / misoprostol (non-enteric coated mantle) 200 MCG Oral Tablet
- RxCUI: 1359105 - diclofenac sodium 75 MG / misoprostol 200 MCG Delayed Release Oral Tablet
- RxCUI: 857706 - diclofenac sodium 50 MG / miSOPROStol 0.2 MG Delayed Release Oral Tablet
Clinical Specifications
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Prostaglandin E1 Analog - [EPC] (Established Pharmacologic Class)
- Prostaglandins E, Synthetic - [CS]
Regulatory & Marketing
Hierarchy Structure
- 42571 - Micro Labs Limited
- 42571-133 - Diclofenac Sodium/misoprostol
- 42571-133-29 - 60 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
- 42571-133 - Diclofenac Sodium/misoprostol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42571-133). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42571-133-29 identifies a specific commercial package of 60 blister pack in 1 carton / 10 tablet in 1 blister pack of Diclofenac Sodium/misoprostol Diclofenac-sodium-misoprostol, a human prescription drug labeled by Micro Labs Limited. This tablet is formulated for oral use and contains diclofenac sodium; misoprostol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Micro Labs Limited on September 01, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Diclofenac is used to reduce pain, swelling, and joint stiffness from arthritis. Diclofenac is known as a nonsteroidal anti-inflammatory drug (NSAID). Misoprostol protects the stomach from diclofenac's irritating effects. This combination medication is used to treat arthritis in people at high risk of getting stomach/intestinal ulcers and complications from the ulcers (such as bleeding). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.
How is this Micro Labs Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42571013329. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.